Temporary treatment interruptions with oral selexipag in pulmonary arterial hypertension: Insights from the Prostacyclin (PGI
Preston, Ioana R
Temporary treatment interruptions with oral selexipag in pulmonary arterial hypertension: Insights from the Prostacyclin (PGI [electronic resource] - The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 03 2018 - 401-408 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1557-3117
10.1016/j.healun.2017.09.024 doi
Acetamides--administration & dosage
Administration, Oral
Antihypertensive Agents--administration & dosage
Double-Blind Method
Female
Humans
Hypertension, Pulmonary--drug therapy
Male
Middle Aged
Pyrazines--administration & dosage
Receptors, Epoprostenol--agonists
Time Factors
Withholding Treatment--statistics & numerical data
Temporary treatment interruptions with oral selexipag in pulmonary arterial hypertension: Insights from the Prostacyclin (PGI [electronic resource] - The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 03 2018 - 401-408 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1557-3117
10.1016/j.healun.2017.09.024 doi
Acetamides--administration & dosage
Administration, Oral
Antihypertensive Agents--administration & dosage
Double-Blind Method
Female
Humans
Hypertension, Pulmonary--drug therapy
Male
Middle Aged
Pyrazines--administration & dosage
Receptors, Epoprostenol--agonists
Time Factors
Withholding Treatment--statistics & numerical data